Cantillon Capital Management Llc Decreased Agilent Technologies Inc (NYSE:A) Stake By $21.28 Million

February 14, 2018 - By Vivian Currie

Investors sentiment increased to 1.4 in Q3 2017. Its up 0.18, from 1.22 in 2017Q2. It is positive, as 26 investors sold A shares while 166 reduced holdings. 74 funds opened positions while 194 raised stakes. 267.56 million shares or 0.84% less from 269.83 million shares in 2017Q2 were reported. Americafirst Cap Limited Liability reported 1% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Hanson Mcclain Inc owns 1,917 shares or 0.01% of their US portfolio. Stralem And Co reported 16,800 shares stake. Washington Bancorporation has 0% invested in Agilent Technologies, Inc. (NYSE:A). Assetmark Inc holds 869 shares. New England Rech & Mgmt owns 6,500 shares or 0.31% of their US portfolio. Hartford Financial accumulated 100 shares. Ahl Ptnrs Ltd Liability Partnership reported 101,474 shares. Quantitative Mgmt Ltd Llc reported 0.06% in Agilent Technologies, Inc. (NYSE:A). Ajo L P owns 697,848 shares. Mastrapasqua Asset Management holds 43,172 shares or 0.57% of its portfolio. Webster Bankshares N A has invested 0.02% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Usa Financial Portformulas holds 0.88% or 57,744 shares. Timessquare Capital Mgmt Limited Com accumulated 0.39% or 912,000 shares. Qcm Cayman Limited holds 0.73% or 4,454 shares in its portfolio.

Since August 16, 2017, it had 0 buys, and 10 insider sales for $14.15 million activity. Kaltenbach Patrick also sold $316,300 worth of Agilent Technologies, Inc. (NYSE:A) shares. $79,200 worth of Agilent Technologies, Inc. (NYSE:A) was sold by HIRSCH DIDIER on Wednesday, September 13. On Monday, December 18 the insider Doak Mark sold $1.06 million. KOH BOON HWEE had sold 4,500 shares worth $286,335 on Wednesday, August 30. 13,007 shares were sold by Grau Dominique, worth $806,434.

William Von Mueffling decreased its stake in Agilent Technologies Inc (NYSE:A) by 6.62% based on its latest 2017Q4 regulatory filing with the SEC. Cantillon Capital Management Llc sold 322,360 shares as the company’s stock rose 8.72% with the market. The hedge fund run by William Von Mueffling held 4.55M shares of the capital goods company at the end of 2017Q4, valued at $304.60 million, down from 4.87M at the end of the previous reported quarter. Cantillon Capital Management Llc who had been investing in Agilent Technologies Inc for a number of months, seems to be less bullish one the $22.05 billion market cap company. The stock decreased 0.13% or $0.09 during the last trading session, reaching $68.34. About 1.83M shares traded. Agilent Technologies, Inc. (NYSE:A) has risen 25.96% since February 14, 2017 and is uptrending. It has outperformed by 9.26% the S&P500.

William von Mueffling graduated with an MBA from Columbia in 1995 and went to work immediately in Germany and France for Deutsche Bank. He would later join Lazard Asset Management where he would become the managing director for hedge funds. His rise at Lazard saw him compared to rock stars. Boasting annual average returns of over 30% for 1998 to 2003, Mueffling gained such laudable numbers mostly by the shorting of technology stocks. He would go on to found Cantillon Capital in 2003, and he remains the present and CEO of that firm today. Cantillon Capital Management Llc is a New York-based hedge fund that was founded by William Von Mueffling. It had more than $12.49 billion assets under management in March, 2014. This fund invests only a small percentage of its assets in equities and options. Taken from Cantillon Capital Management latest Adv, the fund reported to have 21 full and part-time employees. Among which 21 performing investment advisory and research functions. The hedge fund had between 11-25 clients.

Agilent Technologies, Inc. (NYSE:A) Ratings Coverage

Among 14 analysts covering Agilent Technologies (NYSE:A), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. Agilent Technologies has $88 highest and $5 lowest target. $68’s average target is -0.50% below currents $68.34 stock price. Agilent Technologies had 53 analyst reports since August 14, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 18 by Goldman Sachs. Cowen & Co maintained Agilent Technologies, Inc. (NYSE:A) on Tuesday, August 15 with “Hold” rating. The firm earned “Buy” rating on Monday, October 9 by Bank of America. As per Thursday, November 10, the company rating was reinitiated by Leerink Swann. The company was maintained on Wednesday, September 20 by Jefferies. Wells Fargo upgraded the shares of A in report on Thursday, July 13 to “Outperform” rating. The stock has “Buy” rating by Deutsche Bank on Thursday, June 22. The firm has “Buy” rating by Bank of America given on Tuesday, August 15. The stock has “Buy” rating by Goldman Sachs on Wednesday, May 11. Cowen & Co maintained the shares of A in report on Monday, November 20 with “Hold” rating.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company has market cap of $22.05 billion. The Company’s Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. It has a 32.54 P/E ratio. The companyÂ’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.

More recent Agilent Technologies, Inc. (NYSE:A) news were published by: which released: “Agilent Technologies (A) Appoints Dow R. Wilson to Board” on January 18, 2018. Also published the news titled: “Is a Surprise Coming for Agilent Technologies (A) This Earnings Season …” on February 13, 2018.‘s news article titled: “Is a Surprise Coming for Agilent Technologies (A) This Earnings Season?” with publication date: February 13, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.